GO:1903189 glyoxal metabolic process: Reactive Dicarbonyl Detoxification, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1903189 glyoxal metabolic process describes the chemical reactions and pathways involving glyoxal, a highly reactive 1,2-dicarbonyl compound.
• Glyoxal is formed endogenously and exogenously, including from food processing and electronic cigarette aerosols, and drives carbonyl stress.
• The glyoxalase system, centered on GLO1, is the major route for glyoxal and methylglyoxal detoxification, converting them to less reactive metabolites.
• Dysregulated glyoxal metabolism contributes to diabetic complications, cardiovascular disease, cancer, and multiple sclerosis through advanced glycation endproducts (AGEs).
• Key genes include GLO1, GLO2, GSR, and AGXT2, which are studied using CRISPR knockout, point mutation, and overexpression models.
• Research methods span metabolomics, proteomics, CRISPR screening, and bioinformatics to map glyoxal flux and its pathological consequences.
Description
Glyoxal metabolic process (GO:1903189) is defined as the chemical reactions and pathways involving glyoxal, a small, highly reactive 1,2-dicarbonyl compound. Glyoxal is generated endogenously during lipid peroxidation and glucose autoxidation, and exogenously from food processing, cigarette smoke, and electronic cigarette aerosols. Because glyoxal readily modifies proteins, nucleic acids, and lipids, its metabolism is critical for cellular homeostasis. This GO term encompasses the enzymatic and non-enzymatic steps that produce, transform, and eliminate glyoxal, thereby limiting carbonyl stress. Researchers study glyoxal metabolic process to understand how cells cope with reactive dicarbonyls and how failure of this process contributes to human disease. The term is particularly relevant to diabetes, cardiovascular disorders, cancer, and neurodegenerative conditions, where glyoxal and its methylglyoxal counterpart accumulate. In this article, we integrate the QuickGO definition with verified PubMed literature to provide a research-grade overview of glyoxal metabolic process, its genes, regulation, disease links, and experimental models.
glyoxal metabolic process At A Glance
| GO ID | GO:1903189 |
|---|---|
| GO term | glyoxal metabolic process |
| Ontology | biological_process |
| Synonym | glyoxal metabolism |
| Definition | The chemical reactions and pathways involving glyoxal. |
| Major function | Detoxification of glyoxal and prevention of carbonyl stress |
| Key enzymes | GLO1, GLO2, GSR, AGXT2 |
| Associated diseases | Diabetes, cardiovascular disease, cancer, multiple sclerosis |
| Research methods | Metabolomics, proteomics, CRISPR screening, bioinformatics |
What Is GO:1903189?
GO:1903189 glyoxal metabolic process refers to the sum of chemical reactions and pathways that involve glyoxal, a reactive dicarbonyl metabolite. This includes the formation of glyoxal from precursors such as glucose, lipids, and ascorbate, its conjugation with glutathione, its conversion to glycolate or other products, and its detoxification via the glyoxalase system. The process is essential for preventing the accumulation of glyoxal, which can non-enzymatically glycate proteins and form advanced glycation endproducts (AGEs).
Why Is glyoxal metabolic process Important in Cell Biology?
Glyoxal metabolic process is important because glyoxal is a potent glycating agent that modifies proteins and DNA, leading to cellular dysfunction. Its dysregulation is implicated in diabetic complications, cardiovascular disease, cancer, and multiple sclerosis. Understanding this process provides insights into carbonyl stress and identifies therapeutic targets for metabolic disorders.
• Glyoxal is a major precursor of advanced glycation endproducts (AGEs) linked to diabetic complications.
• The glyoxalase system, especially GLO1, is the primary detoxification route for glyoxal and methylglyoxal.
• Glyoxal metabolism influences cancer cell survival and proliferation through metabolic reprogramming.
• Carbonyl stress from glyoxal contributes to cardiovascular events in diabetic patients.
• Glyoxal and methylglyoxal are implicated in neuroinflammation and multiple sclerosis.
• Food-derived glyoxal and methylglyoxal may affect health and disease risk.
• Electronic cigarettes generate glyoxal, raising concerns about inhalation exposure.
• Ascorbate autoxidation can produce glyoxal-related modifications such as lysine N-pyrrolation.
• Glyoxal metabolism is a target for therapeutic intervention in metabolic disorders.
• CRISPR models enable functional dissection of glyoxal metabolic genes.
What Happens During glyoxal metabolic process?
Formation of glyoxal
In simple terms: Glyoxal is made when sugars or fats break down in the body or during food processing.
Glyoxal is formed endogenously via glucose autoxidation, lipid peroxidation, and ascorbate autoxidation. Exogenous sources include heat-processed foods, cigarette smoke, and electronic cigarette aerosols. These pathways generate glyoxal as a reactive dicarbonyl that can modify macromolecules.
Detoxification by the glyoxalase system
In simple terms: The glyoxalase system converts glyoxal into a harmless product using glutathione.
The glyoxalase system, comprising GLO1 and GLO2, converts glyoxal and methylglyoxal to S-D-lactoylglutathione and then to D-lactate, using glutathione as a cofactor. This pathway is the major route for glyoxal detoxification and prevents AGE formation.
Alternative metabolic routes
In simple terms: Other enzymes can also help break down glyoxal.
AGXT2 and other enzymes can metabolize glyoxal or its precursors. Additionally, glyoxal can be reduced to glycolaldehyde or oxidized to glyoxylic acid, although these pathways are less characterized.
Consequences of impaired glyoxal metabolism
In simple terms: When glyoxal is not cleared, it damages proteins and contributes to disease.
Accumulation of glyoxal leads to advanced glycation endproducts (AGEs), which are associated with diabetic complications, cardiovascular disease, and neurodegeneration. Carbonyl stress from glyoxal also affects cancer cell metabolism.
Key Genes Involved in GO:1903189 glyoxal metabolic process
The following genes encode enzymes and proteins directly involved in glyoxal metabolic process, as supported by published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| GLO1 | Primary enzyme detoxifying glyoxal and methylglyoxal | Target for cancer and diabetes studies |
| GLO2 | Second enzyme in glyoxalase system | Completes detoxification pathway |
| GSR | Regenerates glutathione, cofactor for GLO1 | Modulates glyoxalase system capacity |
| AGXT2 | Metabolizes glyoxal and related dicarbonyls | Alternative detoxification route |
| G6PD | Provides NADPH for glutathione regeneration | Supports glyoxalase system |
| TXN | Thioredoxin, reduces oxidative stress | Indirectly affects glyoxal metabolism |
| NQO1 | Quinone oxidoreductase, antioxidant | May influence carbonyl stress |
| SLC7A11 | Cystine transporter for glutathione synthesis | Regulates glutathione availability |
| GCLC | Glutamate-cysteine ligase, glutathione synthesis | Limits glyoxalase system substrate |
| GCLM | Modulatory subunit of GCLC | Regulates glutathione synthesis |
| GSS | Glutathione synthetase | Final step of glutathione synthesis |
| GSTP1 | Glutathione S-transferase, detoxifies reactive compounds | May conjugate glyoxal |
| ALDH2 | Aldehyde dehydrogenase, oxidizes aldehydes | Potential glyoxal oxidation |
| AKR1B1 | Aldose reductase, reduces dicarbonyls | Alternative detoxification |
| CBS | Cystathionine beta-synthase, transsulfuration | Affects glutathione and glyoxal metabolism |
| MTHFR | Methylenetetrahydrofolate reductase | Influences homocysteine and glyoxal stress |
| AGER | Receptor for AGEs | Mediates effects of glyoxal-derived AGEs |
How Is glyoxal metabolic process Regulated?
Glyoxal metabolic process is regulated at multiple levels. The glyoxalase system is induced under oxidative stress via Nrf2-mediated transcription of GLO1 and glutathione synthesis genes. Glyoxal levels are also influenced by dietary intake and detoxification capacity. In cancer, glycolytic flux increases methylglyoxal production, upregulating GLO1 to support survival. In diabetes, hyperglycemia enhances glyoxal formation and impairs detoxification, contributing to carbonyl stress.
glyoxal metabolic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| GLO1 | Diabetes, cancer | Knockout and overexpression in cell lines |
| GLO2 | Metabolic disorders | Point mutation to assess catalytic activity |
| AGER | Inflammation, MS | Knock-in of human variant |
| AGXT2 | Cardiovascular disease | Knockout in endothelial cells |
| GSR | Oxidative stress | Overexpression to enhance detoxification |
Glyoxal metabolism in diabetes and cardiovascular disease
In diabetes, hyperglycemia increases glyoxal and methylglyoxal formation, leading to AGE accumulation and vascular damage. Carbonyl stress from glyoxal is associated with acute coronary syndrome in diabetic patients. The glyoxalase system, particularly GLO1, is critical for preventing these complications.
Glyoxal metabolism in cancer
Cancer cells exhibit altered glyoxal metabolism, often upregulating GLO1 to detoxify methylglyoxal generated by increased glycolysis. This adaptation supports proliferation and survival, making GLO1 a potential therapeutic target.
Glyoxal metabolism in multiple sclerosis
Methylglyoxal-derived AGEs are implicated in the pathogenesis of multiple sclerosis, contributing to neuroinflammation and demyelination. Glyoxal metabolic process may therefore influence disease progression.
Glyoxal metabolism in food and environmental exposure
Food-derived glyoxal and methylglyoxal are linked to health risks, including cancer and metabolic disorders. Electronic cigarettes generate glyoxal, raising concerns about inhalation exposure.
From glyoxal metabolic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does GLO1 loss increase glyoxal sensitivity? | GLO1 knockout cell line |
| Does a GLO1 point mutation affect catalytic efficiency? | Point-mutation knock-in |
| Can GLO1 overexpression protect against carbonyl stress? | Overexpression cell model |
| How does glyoxal affect signaling pathways? | Tagged knock-in for live imaging |
| What genes modulate glyoxal toxicity? | CRISPR library screening |
| Can we map glyoxal metabolic flux? | Metabolomics with isotope tracing |
How to Study the glyoxal metabolic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| LC-MS/MS metabolomics | Glyoxal and metabolite levels | Quantify glyoxal in cells and tissues |
| Proteomics | Protein glycation by glyoxal | Identify AGE-modified proteins |
| CRISPR knockout screening | Genes affecting glyoxal toxicity | Discover novel regulators |
| RNA-seq | Transcriptional response to glyoxal | Map gene expression changes |
| Western blot | GLO1 and GLO2 protein levels | Validate expression changes |
| Enzyme activity assay | GLO1 catalytic activity | Assess functional impact of mutations |
| Immunohistochemistry | AGE accumulation in tissues | Link glyoxal to disease pathology |
Metabolomics and flux analysis
Metabolomics using LC-MS/MS quantifies glyoxal, methylglyoxal, and their metabolites. Isotope tracing can map flux through the glyoxalase system.
Proteomics and glycation profiling
Proteomic approaches identify proteins modified by glyoxal-derived AGEs, revealing affected pathways. This helps link glyoxal metabolism to disease mechanisms.
CRISPR screening
Genome-wide CRISPR knockout screens can identify genes that modulate sensitivity to glyoxal or methylglyoxal. This unbiased approach uncovers novel regulators of glyoxal metabolic process.
Bioinformatics and pathway analysis
Bioinformatics tools integrate transcriptomic and metabolomic data to reconstruct glyoxal metabolic networks. Pathway enrichment analysis highlights disease associations.
How CRISPR Can Be Used to Study GO:1903189 glyoxal metabolic process
Knockout
CRISPR knockout of GLO1 or GLO2 in cell lines abolishes glyoxal detoxification, increasing sensitivity to glyoxal and methylglyoxal. These models are used to study carbonyl stress and identify compensatory pathways.
Point Mutation
Point mutations in GLO1 catalytic residues can be introduced to dissect enzyme mechanism and assess the impact on glyoxal metabolism. Such models help validate structural predictions.
Knock-in
Knock-in of tagged GLO1 or disease-associated variants allows live-cell imaging and functional studies of glyoxal metabolic process. This approach can reveal subcellular localization and dynamics.
Overexpression
Overexpression of GLO1 or GLO2 enhances glyoxal detoxification and protects against carbonyl stress. These models are useful for testing therapeutic strategies.
How EDITGENE Supports glyoxal metabolic process Research
Researchers studying glyoxal metabolic process-related genes often need to determine whether a candidate gene is causally involved in glyoxal detoxification, disease progression, or therapeutic response. EDITGENE provides a comprehensive suite of CRISPR services to accelerate this research.
Contact EDITGENE today to design your custom CRISPR model for glyoxal metabolic process research.
Frequently Asked Questions About glyoxal metabolic process
What is glyoxal metabolic process?
Glyoxal metabolic process (GO:1903189) is the set of chemical reactions and pathways involving glyoxal, a reactive dicarbonyl compound.
What genes are involved in glyoxal metabolic process?
Key genes include GLO1, GLO2, GSR, AGXT2, and others involved in glyoxal detoxification and glutathione metabolism.
How is glyoxal detoxified in cells?
The glyoxalase system, primarily GLO1 and GLO2, converts glyoxal to D-lactate using glutathione.
What diseases are linked to glyoxal metabolism?
Dysregulated glyoxal metabolism is linked to diabetes, cardiovascular disease, cancer, and multiple sclerosis.
What is the role of GLO1 in glyoxal metabolism?
GLO1 is the rate-limiting enzyme that detoxifies glyoxal and methylglyoxal, preventing AGE formation.
How can I study glyoxal metabolic process?
Use metabolomics, proteomics, CRISPR screening, and bioinformatics to map glyoxal flux and identify regulators.
What are advanced glycation endproducts (AGEs)?
AGEs are harmful modifications of proteins by sugars and dicarbonyls like glyoxal, implicated in diabetic complications.
Is glyoxal found in food?
Yes, glyoxal and methylglyoxal are formed during food processing and are present in various foods.
Can CRISPR be used to study glyoxal metabolism?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are powerful tools to dissect glyoxal metabolic genes.
What is carbonyl stress?
Carbonyl stress is the detrimental accumulation of reactive carbonyl compounds like glyoxal, leading to protein damage.
Conclusion
Glyoxal metabolic process (GO:1903189) is a critical biological process that protects cells from reactive dicarbonyl damage. Its dysregulation is implicated in major human diseases, including diabetes, cardiovascular disease, cancer, and multiple sclerosis. Understanding the genes and pathways involved offers opportunities for therapeutic intervention. Advanced CRISPR models and multi-omics approaches are essential to unravel the complexities of glyoxal metabolism and translate findings into clinical applications.
References
- 1. Bekki K et al.. 2014. Carbonyl compounds generated from electronic cigarettes.. Int J Environ Res Public Health 11(11):11192-200 PMID: 25353061
- 2. Zhang M et al.. 2024. Glyoxal in Foods: Formation, Metabolism, Health Hazards, and Its Control Strategies.. J Agric Food Chem 72(5):2434-2450 PMID: 38284798
- 3. Wetzels S et al.. 2017. Methylglyoxal-Derived Advanced Glycation Endproducts in Multiple Sclerosis.. Int J Mol Sci 18(2) PMID: 28212304
- 4. Yoshitake J et al.. 2022. Autoxidation of ascorbate mediates lysine N-pyrrolation.. Free Radic Res 56(11-12):749-759 PMID: 36725333
- 5. Alfarouk KO et al.. 2021. The possible role of methylglyoxal metabolism in cancer.. J Enzyme Inhib Med Chem 36(1):2010-2015 PMID: 34517737
- 6. Bora S et al.. 2021. Carbonyl stress in diabetics with acute coronary syndrome.. Clin Chim Acta 520:78-86 PMID: 34090879
- 7. Ahmad S et al.. 2020. Impact of Reactive Dicarbonyls on Biological Macromolecules- Role in Metabolic Disorders.. Curr Protein Pept Sci 21(9):844-845 PMID: 33323095
- 8. Hellwig M et al.. 2018. Food-derived 1,2-dicarbonyl compounds and their role in diseases.. Semin Cancer Biol 49:1-8 PMID: 29174601
